India · Delayed Price · Currency is INR MedPlus Health Services Statistics
Total Valuation
NSE:MEDPLUS has a market cap or net worth of INR 92.91 billion. The enterprise value is 99.82 billion.
| Market Cap | 92.91B |
| Enterprise Value | 99.82B |
Important Dates
The next estimated earnings date is Friday, January 30, 2026.
| Earnings Date | Jan 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:MEDPLUS has 119.82 million shares outstanding. The number of shares has decreased by -0.11% in one year.
| Current Share Class | 119.82M |
| Shares Outstanding | 119.82M |
| Shares Change (YoY) | -0.11% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 13.32% |
| Owned by Institutions (%) | 39.12% |
| Float | 69.44M |
Valuation Ratios
The trailing PE ratio is 47.71 and the forward PE ratio is 42.73. NSE:MEDPLUS's PEG ratio is 1.64.
| PE Ratio | 47.71 |
| Forward PE | 42.73 |
| PS Ratio | 1.48 |
| PB Ratio | 5.04 |
| P/TBV Ratio | 5.18 |
| P/FCF Ratio | 18.29 |
| P/OCF Ratio | 15.99 |
| PEG Ratio | 1.64 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.89, with an EV/FCF ratio of 19.65.
| EV / Earnings | 51.17 |
| EV / Sales | 1.59 |
| EV / EBITDA | 17.89 |
| EV / EBIT | 33.21 |
| EV / FCF | 19.65 |
Financial Position
The company has a current ratio of 2.90, with a Debt / Equity ratio of 0.65.
| Current Ratio | 2.90 |
| Quick Ratio | 0.77 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 2.14 |
| Debt / FCF | 2.35 |
| Interest Coverage | 2.76 |
Financial Efficiency
Return on equity (ROE) is 11.21% and return on invested capital (ROIC) is 9.74%.
| Return on Equity (ROE) | 11.21% |
| Return on Assets (ROA) | 5.59% |
| Return on Invested Capital (ROIC) | 9.74% |
| Return on Capital Employed (ROCE) | 10.38% |
| Weighted Average Cost of Capital (WACC) | 7.29% |
| Revenue Per Employee | 2.52M |
| Profits Per Employee | 78,011 |
| Employee Count | 25,007 |
| Asset Turnover | 1.87 |
| Inventory Turnover | 3.57 |
Taxes
In the past 12 months, NSE:MEDPLUS has paid 443.84 million in taxes.
| Income Tax | 443.84M |
| Effective Tax Rate | 18.54% |
Stock Price Statistics
The stock price has increased by +4.29% in the last 52 weeks. The beta is 0.55, so NSE:MEDPLUS's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +4.29% |
| 50-Day Moving Average | 806.95 |
| 200-Day Moving Average | 831.02 |
| Relative Strength Index (RSI) | 36.83 |
| Average Volume (20 Days) | 85,655 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:MEDPLUS had revenue of INR 62.93 billion and earned 1.95 billion in profits. Earnings per share was 16.25.
| Revenue | 62.93B |
| Gross Profit | 16.09B |
| Operating Income | 3.01B |
| Pretax Income | 2.39B |
| Net Income | 1.95B |
| EBITDA | 3.73B |
| EBIT | 3.01B |
| Earnings Per Share (EPS) | 16.25 |
Balance Sheet
The company has 5.02 billion in cash and 11.93 billion in debt, with a net cash position of -6.91 billion or -57.68 per share.
| Cash & Cash Equivalents | 5.02B |
| Total Debt | 11.93B |
| Net Cash | -6.91B |
| Net Cash Per Share | -57.68 |
| Equity (Book Value) | 18.44B |
| Book Value Per Share | 153.91 |
| Working Capital | 12.88B |
Cash Flow
In the last 12 months, operating cash flow was 5.81 billion and capital expenditures -731.50 million, giving a free cash flow of 5.08 billion.
| Operating Cash Flow | 5.81B |
| Capital Expenditures | -731.50M |
| Free Cash Flow | 5.08B |
| FCF Per Share | 42.39 |
Margins
Gross margin is 25.57%, with operating and profit margins of 4.78% and 3.10%.
| Gross Margin | 25.57% |
| Operating Margin | 4.78% |
| Pretax Margin | 3.80% |
| Profit Margin | 3.10% |
| EBITDA Margin | 5.92% |
| EBIT Margin | 4.78% |
| FCF Margin | 8.07% |
Dividends & Yields
NSE:MEDPLUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.11% |
| Shareholder Yield | 0.11% |
| Earnings Yield | 2.10% |
| FCF Yield | 5.47% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |